Literature DB >> 12559221

Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure.

A P Coletta1, N Nikitin, A L Clark, J G F Cleland.   

Abstract

This article continues a series of reports on research developments of particular interest to those involved in the management of patients with heart failure. Summaries of the following trials, reported at the 75th Scientific Sessions of the American Heart Association held in Chicago, Illinois between 17th and 20th November 2002 are included: PROSPER; DIAL; home care monitoring trials; immune modulation therapy; COMPANION; and anaemia in heart failure.

Entities:  

Mesh：

Year:  2003        PMID： 12559221     DOI： 10.1016/s1388-9842(02)00249-0

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


  3 in total

1.  [New technologies in the optimization of CRT programming].

Authors:  A Kloppe; B Lemke; M Zarse
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-03

2.  Effects of therapy using the Celacade system on structural and functional cardiac remodelling in rats following myocardial infarction.

Authors:  Mei Luo Zhang; Jie Mei; Lori Anne Archer; Masakazu Obayashi; Ni Diao; Bruno Stuyvers; Henk E D J ter Keurs
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

3.  Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients.

Authors:  Jean-Christophe Luthi; W Dana Flanders; Michel Burnier; Bernard Burnand; William M McClellan
Journal:  BMC Nephrol       Date:  2006-03-06       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.